In BL cell lines, it has been demonstrated that the ECM protein fibronectin, following binding of alphavbeta3-integrin expressed on neoplastic cell surface, activates signal transduction pathways leading to BL cell proliferation by phosphorylation of the MAP kinase ERK-2 [92]. The gene discussed is FN1; the disease is Burkitt lymphoma.